GlassScriptPhysician profile
Abdul Gaffar Chaudry
NPI 1356435002
$776.99
in general payments reported to CMS, 2019-2025
9 companies · $6.11 in 2025
The $6.11 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.17 · 2020: $42.24 · 2021: $254 · 2022: $140 · 2024: $271 · 2025: $6.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.58 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $271.46 | 2024 | Veozah |
| Myovant Sciences INC. | $166.42 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $119.48 | 2021 | |
| Mylan Pharmaceuticals INC. | $73.61 | 2019-2022 | |
| Medtronic, INC. | $71.23 | 2021 | |
| Abbvie INC. | $32.62 | 2019-2020 | |
| Abbott Laboratories | $22.27 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.79 | 2019 | |
| Organon LLC | $6.11 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Chaudry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.